Financhill
Sell
37

PATH Quote, Financials, Valuation and Earnings

Last price:
$13.12
Seasonality move :
-7.03%
Day range:
$13.13 - $14.10
52-week range:
$10.37 - $27.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.28x
P/B ratio:
4.19x
Volume:
9.9M
Avg. volume:
10.3M
1-year change:
-41.62%
Market cap:
$7.3B
Revenue:
$1.3B
EPS (TTM):
-$0.16

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
PATH
UiPath
$347.7M $0.07 4.98% 220.3% $15.73
CNXC
Concentrix
$2.4B $3.01 9.47% 181.84% $72.17
DV
DoubleVerify Holdings
$197M $0.32 14.36% 66.07% $22.80
SABR
Sabre
$720M -$0.10 5.25% -56.52% $4.40
WYY
WidePoint
$30M -- 6.12% -- $6.50
ZETA
Zeta Global Holdings
$294.9M $0.22 40.19% -- $37.54
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
PATH
UiPath
$13.20 $15.73 $7.3B -- $0.00 0% 5.28x
CNXC
Concentrix
$45.79 $72.17 $3B 14.87x $0.33 2.71% 0.31x
DV
DoubleVerify Holdings
$19.22 $22.80 $3.2B 51.95x $0.00 0% 5.28x
SABR
Sabre
$3.46 $4.40 $1.3B -- $0.00 0% 0.44x
WYY
WidePoint
$4.50 $6.50 $44.1M -- $0.00 0% 0.31x
ZETA
Zeta Global Holdings
$18.18 $37.54 $4.3B -- $0.00 0% 3.53x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
PATH
UiPath
-- 1.184 -- 2.90x
CNXC
Concentrix
54.09% 1.405 101.39% 1.20x
DV
DoubleVerify Holdings
-- 0.175 -- 6.30x
SABR
Sabre
144.79% -1.034 348.79% 0.92x
WYY
WidePoint
-- 4.362 -- 1.02x
ZETA
Zeta Global Holdings
29.23% 0.576 2.85% 3.26x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
PATH
UiPath
$290.9M -$43.4M -4.78% -4.78% -12.23% $23.2M
CNXC
Concentrix
$864.2M $153.2M 2.37% 5.29% 4.49% $128.9M
DV
DoubleVerify Holdings
$140.1M $25.7M 6.09% 6.09% 17.66% $48.4M
SABR
Sabre
$231.2M $70.1M -8.52% -- 9.34% $7.6M
WYY
WidePoint
$4.7M -$451K -20.12% -20.12% -1.13% $1.8M
ZETA
Zeta Global Holdings
$162.6M -$7.8M -28.02% -49.55% -5.68% $25.6M

UiPath vs. Competitors

  • Which has Higher Returns PATH or CNXC?

    Concentrix has a net margin of -3% compared to UiPath's net margin of 0.7%. UiPath's return on equity of -4.78% beat Concentrix's return on equity of 5.29%.

    Company Gross Margin Earnings Per Share Invested Capital
    PATH
    UiPath
    82.02% -$0.02 $1.7B
    CNXC
    Concentrix
    36.2% $0.25 $9.1B
  • What do Analysts Say About PATH or CNXC?

    UiPath has a consensus price target of $15.73, signalling upside risk potential of 19.15%. On the other hand Concentrix has an analysts' consensus of $72.17 which suggests that it could grow by 57.6%. Given that Concentrix has higher upside potential than UiPath, analysts believe Concentrix is more attractive than UiPath.

    Company Buy Ratings Hold Ratings Sell Ratings
    PATH
    UiPath
    2 20 1
    CNXC
    Concentrix
    2 2 0
  • Is PATH or CNXC More Risky?

    UiPath has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Concentrix has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock PATH or CNXC?

    UiPath has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Concentrix offers a yield of 2.71% to investors and pays a quarterly dividend of $0.33 per share. UiPath pays -- of its earnings as a dividend. Concentrix pays out 20.23% of its earnings as a dividend. Concentrix's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios PATH or CNXC?

    UiPath quarterly revenues are $354.7M, which are smaller than Concentrix quarterly revenues of $2.4B. UiPath's net income of -$10.7M is lower than Concentrix's net income of $16.6M. Notably, UiPath's price-to-earnings ratio is -- while Concentrix's PE ratio is 14.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UiPath is 5.28x versus 0.31x for Concentrix. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    PATH
    UiPath
    5.28x -- $354.7M -$10.7M
    CNXC
    Concentrix
    0.31x 14.87x $2.4B $16.6M
  • Which has Higher Returns PATH or DV?

    DoubleVerify Holdings has a net margin of -3% compared to UiPath's net margin of 10.74%. UiPath's return on equity of -4.78% beat DoubleVerify Holdings's return on equity of 6.09%.

    Company Gross Margin Earnings Per Share Invested Capital
    PATH
    UiPath
    82.02% -$0.02 $1.7B
    DV
    DoubleVerify Holdings
    82.61% $0.10 $1.1B
  • What do Analysts Say About PATH or DV?

    UiPath has a consensus price target of $15.73, signalling upside risk potential of 19.15%. On the other hand DoubleVerify Holdings has an analysts' consensus of $22.80 which suggests that it could grow by 18.63%. Given that UiPath has higher upside potential than DoubleVerify Holdings, analysts believe UiPath is more attractive than DoubleVerify Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    PATH
    UiPath
    2 20 1
    DV
    DoubleVerify Holdings
    6 5 1
  • Is PATH or DV More Risky?

    UiPath has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DoubleVerify Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock PATH or DV?

    UiPath has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DoubleVerify Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UiPath pays -- of its earnings as a dividend. DoubleVerify Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios PATH or DV?

    UiPath quarterly revenues are $354.7M, which are larger than DoubleVerify Holdings quarterly revenues of $169.6M. UiPath's net income of -$10.7M is lower than DoubleVerify Holdings's net income of $18.2M. Notably, UiPath's price-to-earnings ratio is -- while DoubleVerify Holdings's PE ratio is 51.95x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UiPath is 5.28x versus 5.28x for DoubleVerify Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    PATH
    UiPath
    5.28x -- $354.7M -$10.7M
    DV
    DoubleVerify Holdings
    5.28x 51.95x $169.6M $18.2M
  • Which has Higher Returns PATH or SABR?

    Sabre has a net margin of -3% compared to UiPath's net margin of -8.22%. UiPath's return on equity of -4.78% beat Sabre's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    PATH
    UiPath
    82.02% -$0.02 $1.7B
    SABR
    Sabre
    30.23% -$0.16 $3.5B
  • What do Analysts Say About PATH or SABR?

    UiPath has a consensus price target of $15.73, signalling upside risk potential of 19.15%. On the other hand Sabre has an analysts' consensus of $4.40 which suggests that it could grow by 31.17%. Given that Sabre has higher upside potential than UiPath, analysts believe Sabre is more attractive than UiPath.

    Company Buy Ratings Hold Ratings Sell Ratings
    PATH
    UiPath
    2 20 1
    SABR
    Sabre
    1 5 0
  • Is PATH or SABR More Risky?

    UiPath has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Sabre has a beta of 1.799, suggesting its more volatile than the S&P 500 by 79.889%.

  • Which is a Better Dividend Stock PATH or SABR?

    UiPath has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Sabre offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UiPath pays -- of its earnings as a dividend. Sabre pays out -3.04% of its earnings as a dividend.

  • Which has Better Financial Ratios PATH or SABR?

    UiPath quarterly revenues are $354.7M, which are smaller than Sabre quarterly revenues of $764.7M. UiPath's net income of -$10.7M is higher than Sabre's net income of -$62.8M. Notably, UiPath's price-to-earnings ratio is -- while Sabre's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UiPath is 5.28x versus 0.44x for Sabre. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    PATH
    UiPath
    5.28x -- $354.7M -$10.7M
    SABR
    Sabre
    0.44x -- $764.7M -$62.8M
  • Which has Higher Returns PATH or WYY?

    WidePoint has a net margin of -3% compared to UiPath's net margin of -1.23%. UiPath's return on equity of -4.78% beat WidePoint's return on equity of -20.12%.

    Company Gross Margin Earnings Per Share Invested Capital
    PATH
    UiPath
    82.02% -$0.02 $1.7B
    WYY
    WidePoint
    13.55% -$0.04 $13.8M
  • What do Analysts Say About PATH or WYY?

    UiPath has a consensus price target of $15.73, signalling upside risk potential of 19.15%. On the other hand WidePoint has an analysts' consensus of $6.50 which suggests that it could grow by 44.44%. Given that WidePoint has higher upside potential than UiPath, analysts believe WidePoint is more attractive than UiPath.

    Company Buy Ratings Hold Ratings Sell Ratings
    PATH
    UiPath
    2 20 1
    WYY
    WidePoint
    1 0 0
  • Is PATH or WYY More Risky?

    UiPath has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison WidePoint has a beta of 1.716, suggesting its more volatile than the S&P 500 by 71.556%.

  • Which is a Better Dividend Stock PATH or WYY?

    UiPath has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. WidePoint offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UiPath pays -- of its earnings as a dividend. WidePoint pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios PATH or WYY?

    UiPath quarterly revenues are $354.7M, which are larger than WidePoint quarterly revenues of $34.6M. UiPath's net income of -$10.7M is lower than WidePoint's net income of -$425.2K. Notably, UiPath's price-to-earnings ratio is -- while WidePoint's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UiPath is 5.28x versus 0.31x for WidePoint. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    PATH
    UiPath
    5.28x -- $354.7M -$10.7M
    WYY
    WidePoint
    0.31x -- $34.6M -$425.2K
  • Which has Higher Returns PATH or ZETA?

    Zeta Global Holdings has a net margin of -3% compared to UiPath's net margin of -6.48%. UiPath's return on equity of -4.78% beat Zeta Global Holdings's return on equity of -49.55%.

    Company Gross Margin Earnings Per Share Invested Capital
    PATH
    UiPath
    82.02% -$0.02 $1.7B
    ZETA
    Zeta Global Holdings
    60.62% -$0.09 $671M
  • What do Analysts Say About PATH or ZETA?

    UiPath has a consensus price target of $15.73, signalling upside risk potential of 19.15%. On the other hand Zeta Global Holdings has an analysts' consensus of $37.54 which suggests that it could grow by 106.48%. Given that Zeta Global Holdings has higher upside potential than UiPath, analysts believe Zeta Global Holdings is more attractive than UiPath.

    Company Buy Ratings Hold Ratings Sell Ratings
    PATH
    UiPath
    2 20 1
    ZETA
    Zeta Global Holdings
    8 4 0
  • Is PATH or ZETA More Risky?

    UiPath has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Zeta Global Holdings has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock PATH or ZETA?

    UiPath has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Zeta Global Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UiPath pays -- of its earnings as a dividend. Zeta Global Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios PATH or ZETA?

    UiPath quarterly revenues are $354.7M, which are larger than Zeta Global Holdings quarterly revenues of $268.3M. UiPath's net income of -$10.7M is higher than Zeta Global Holdings's net income of -$17.4M. Notably, UiPath's price-to-earnings ratio is -- while Zeta Global Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UiPath is 5.28x versus 3.53x for Zeta Global Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    PATH
    UiPath
    5.28x -- $354.7M -$10.7M
    ZETA
    Zeta Global Holdings
    3.53x -- $268.3M -$17.4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SCHD a Good ETF to Buy?
Is SCHD a Good ETF to Buy?

With around $65.7 billion in net assets, Schwab’s US Dividend…

Is NAIL a Good ETF to Buy?
Is NAIL a Good ETF to Buy?

If you’re thinking about buying the NAIL ETF, this article…

3 High Dividend Dow Jones Stocks
3 High Dividend Dow Jones Stocks

Thanks to surging stock prices over the past two years,…

Stock Ideas

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
57
NARI alert for Jan 8

Inari Medical [NARI] is down 0.01% over the past day.

Buy
69
UNF alert for Jan 8

UniFirst [UNF] is down 0.34% over the past day.

Sell
31
APOG alert for Jan 8

Apogee Enterprises [APOG] is down 10.02% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock